365 related articles for article (PubMed ID: 38235406)
1. Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities.
Wang J; Zhao Y; Nie G
Med Rev (2021); 2023 Aug; 3(4):321-342. PubMed ID: 38235406
[TBL] [Abstract][Full Text] [Related]
2. Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.
Katopodi T; Petanidis S; Tsavlis D; Anestakis D; Charalampidis C; Chatziprodromidou I; Eskitzis P; Zarogoulidis P; Kosmidis C; Matthaios D; Porpodis K
Front Oncol; 2022; 12():1042125. PubMed ID: 36338748
[TBL] [Abstract][Full Text] [Related]
3. Advances in intelligent-responsive nanocarriers for cancer therapy.
Tian M; Xin X; Wu R; Guan W; Zhou W
Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Nano-Bio Interactions and the Corresponding Biological Responses.
Tian X; Chong Y; Ge C
Front Chem; 2020; 8():446. PubMed ID: 32587847
[TBL] [Abstract][Full Text] [Related]
5. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
Wang Y; Cai R; Chen C
Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
[TBL] [Abstract][Full Text] [Related]
6. Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.
Guo L; Yang J; Wang H; Yi Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067480
[TBL] [Abstract][Full Text] [Related]
7. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials.
Bukhari SNA
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456698
[TBL] [Abstract][Full Text] [Related]
8. Nano-bio interactions: A major principle in the dynamic biological processes of nano-assemblies.
Liu J; Guo M; Chen C
Adv Drug Deliv Rev; 2022 Jul; 186():114318. PubMed ID: 35533787
[TBL] [Abstract][Full Text] [Related]
9. Protein adsorption onto nanomaterials engineered for theranostic applications.
Nienhaus K; Xue Y; Shang L; Nienhaus GU
Nanotechnology; 2022 Apr; 33(26):. PubMed ID: 35294940
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy.
Wu M; Niu X; Zhang R; Ping Xu Z
Adv Drug Deliv Rev; 2022 Aug; 187():114360. PubMed ID: 35636568
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Managing Atherosclerosis via Nanomedicine.
Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
Small; 2018 Jan; 14(4):. PubMed ID: 29239134
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicines for Renal Management: From Imaging to Treatment.
Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma.
Yang XY; Lu YF; Xu JX; Du YZ; Yu RS
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771172
[TBL] [Abstract][Full Text] [Related]
14. Smart materials on the way to theranostic nanorobots: Molecular machines and nanomotors, advanced biosensors, and intelligent vehicles for drug delivery.
Sokolov IL; Cherkasov VR; Tregubov AA; Buiucli SR; Nikitin MP
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1530-1544. PubMed ID: 28130158
[TBL] [Abstract][Full Text] [Related]
15. Intelligent Nanomedicine Approaches Using Medical Gas-Mediated Multi-Therapeutic Modalities Against Cancer.
Ren X; Wang Y; Jia L; Guo X; He X; Zhao Z; Gao D; Yang Z
J Biomed Nanotechnol; 2022 Jan; 18(1):24-49. PubMed ID: 35180898
[TBL] [Abstract][Full Text] [Related]
16. Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy.
Wei X; Wang J; Liang M; Song M
Theranostics; 2022; 12(18):7821-7852. PubMed ID: 36451865
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
Zhang Y; Li J; Pu K
Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
[TBL] [Abstract][Full Text] [Related]
18. Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy.
Xiao M; Shi Y; Jiang S; Cao M; Chen W; Xu Y; Xu Z; Wang K
Front Oncol; 2022; 12():1039378. PubMed ID: 36523993
[TBL] [Abstract][Full Text] [Related]
19. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
